This randomized, double-blind, placebo-controlled trial examined the effects of a 300 µg/day testosterone patch on hypoactive sexual desire disorder (HSDD) in naturally menopausal women receiving estrogen therapy. Over 24 weeks, participants using the testosterone patch experienced a significant increase in satisfying sexual activity (mean increase of 2.1 episodes per 4
